Detection of Glycosylated Markers From Cancer Stem Cells With ColoSTEM Dx Kit for Earlier Prediction of Colon Cancer Aggressiveness

Detection of Glycosylated Markers From Cancer Stem Cells With ColoSTEM Dx Kit for Earlier Prediction of Colon Cancer Aggressiveness

Nowadays, colon cancer prognosis still difficult to predict, especially in the early stages. Recurrences remain elevated, even in the early stages after curative surgery. Carcidiag Biotechnologies has developed an immunohistochemistry (IHC) kit called ColoSTEM Dx, based on a MIX of biotinylated plan...

Full description

Bibliographic Details
Main Authors: Sabrina Blondy, Stéphanie Durand, Aurélie Lacroix, Niki Christou, Charline Bouchaud, Maud Peyny, Serge Battu, Alain Chauvanel, Vincent Carré, Marie-Odile Jauberteau, Fabrice Lalloué, Muriel Mathonnet
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Oncology
Subjects:
colorectal carcinoma
early stage
cancer stem cells
glycosylated biomarkers
prognosis value
tumor aggressiveness
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.918702/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.918702/full

Similar Items